Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

For more than a century and a half, the description of a liver as “cirrhotic” was sufficient to connote both a pathological and clinical status, and to assign the prognosis of a patient with liver disease. However, as our interventions to treat advanced liver disease have progressed (e.g., antiviral therapies), the inadequacy of a simple one-stage description for advanced fibrotic liver disease has become increasingly evident. Until recently, refining the diagnosis of cirrhosis into more than one stage hardly seemed necessary when there were no interventions available to arrest its progression. Now, however, understanding the range of potential outcomes based on the severity of cirrhosis is essential in order to predict outcomes and individualize therapy. This position paper, rather than providing clinical guidelines, attempts to catalyze a reformulation of the concept of cirrhosis from a static to a dynamic one, creating a template for further refinement of this concept in the future.

[1]  R. Makuch,et al.  Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. , 2009, Journal of hepatology.

[2]  D. Jain,et al.  233 QUANTITATIVE HISTOLOGICAL ASSESSMENT IN CIRRHOSIS: SEPTAL THICKNESS PREDICTS CLINICAL DECOMPENSATION , 2009 .

[3]  M. Mejías,et al.  Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats , 2009, Hepatology.

[4]  Jaume Bosch,et al.  Angiogenesis in liver disease. , 2009, Journal of hepatology.

[5]  M. Cramp,et al.  Elastography for the non-invasive assessment of liver disease: limitations and future developments. , 2009, Gut.

[6]  Ramon Planas,et al.  Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. , 2007, Gastroenterology.

[7]  R. Groszmann,et al.  Vascular endothelial dysfunction in cirrhosis. , 2007, Journal of hepatology.

[8]  R. Groszmann,et al.  Transient elastography for diagnosis of portal hypertension in liver cirrhosis: Is there still a role for hepatic venous pressure gradient measurement? , 2007, Hepatology.

[9]  Giacomo Belli,et al.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis , 2007, Hepatology.

[10]  X. Forns,et al.  Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  J. Bosch,et al.  Predictions from a hard liver. , 2006, Journal of hepatology.

[12]  X. Forns,et al.  Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation , 2006, Hepatology.

[13]  R. Groszmann,et al.  The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule , 2006, Hepatology.

[14]  S. Friedman,et al.  Reversal of hepatic fibrosis — Fact or fantasy? , 2006, Hepatology.

[15]  R. Groszmann,et al.  Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. , 2006, Journal of hepatology.

[16]  G. D’Amico,et al.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.

[17]  Ramon Planas,et al.  Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. , 2005, The New England journal of medicine.

[18]  Stefano Colagrande,et al.  Fibrosis in chronic liver diseases: diagnosis and management. , 2005, Journal of hepatology.

[19]  F. Sánchez‐Madrid,et al.  Angiogenesis in chronic inflammatory liver disease , 2004, Hepatology.

[20]  A. Burroughs,et al.  Prevention of variceal rebleeding , 2003, The Lancet.

[21]  E. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[22]  P. Bioulac-Sage,et al.  [Mechanisms of hepatic fibrogenesis]. , 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[23]  J. Rodés,et al.  Prognostic value of early measurements of portal pressure in acute variceal bleeding. , 1999, Gastroenterology.

[24]  J. Rodés,et al.  Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. , 1998, Gastroenterology.

[25]  P. Bedossa,et al.  Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.

[26]  K. Batts,et al.  Chronic hepatitis. An update on terminology and reporting. , 1995, The American journal of surgical pathology.

[27]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[28]  R. Groszmann,et al.  Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. , 1990, Gastroenterology.

[29]  S. Sherlock,et al.  Portal hypertension in chronic hepatitis: relationship to morphological changes. , 1990, Gut.

[30]  J. Henriksen,et al.  Correlation Between Liver Morphology and Portal Pressure in Alcoholic Liver Disease , 1984, Hepatology.

[31]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[32]  L. Sobin,et al.  The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. , 1978, Journal of clinical pathology.